www.modernhealthcare.com Open in urlscan Pro
2606:4700::6811:2551  Public Scan

Form analysis
3 forms found in the DOM

GET /search

<form action="/search" method="get" id="views-exposed-form-search-autocomplete-page" accept-charset="UTF-8" data-once="form-updated" data-drupal-form-fields="edit-search-phrase">
  <div class="form--inline clearfix">
    <div class="js-form-item form-item js-form-type-textfield form-type-textfield js-form-item-search-phrase form-item-search-phrase form-no-label">
      <span class="field-prefix">
        <div class="elastic-autocomplete-mobile-search-icon-wrapper"><a class="elastic-autocomplete-mobile-search-icon" href="#"><i class="fa fa-search omnitrack" aria-hidden="true"></i></a></div>
        <div class="elastic-autocomplete-field-wrapper">
          <input class="elastic-autocomplete-input form-autocomplete form-text ui-autocomplete-input" placeholder="Search" data-drupal-selector="edit-search-phrase" data-autocomplete-path="/admin/view_content/search_autocomplete" type="text"
            id="edit-search-phrase" name="search_phrase" value="" size="30" maxlength="128" data-once="autocomplete" autocomplete="off">
          <span class="field-suffix"><a href="#" class="elastic-autocomplete-search-icon"></a></span>
        </div>
      </span>
    </div>
    <input data-drupal-selector="edit-field-emphasis-image" type="hidden" name="field_emphasis_image" value="">
    <input data-drupal-selector="edit-sort-by" type="hidden" name="sort_by" value="search_api_relevance">
    <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"><input data-drupal-selector="edit-submit-search-autocomplete" type="submit" id="edit-submit-search-autocomplete" value="Search"
        class="button js-form-submit form-submit">
    </div>
  </div>
</form>

POST /politics-policy/white-house-without-funding-us-will-lose-covid-treatments

<form class="newsletter-widget-signup-form--1" data-drupal-selector="newsletter-widget-signup-form-1" action="/politics-policy/white-house-without-funding-us-will-lose-covid-treatments" method="post" id="newsletter-widget-signup-form-1"
  accept-charset="UTF-8" data-once="form-updated" data-drupal-form-fields="edit-newsletter-email,edit-newsletter-button">
  <div class="js-form-item form-item js-form-type-textfield form-type-textfield js-form-item-newsletter-email form-item-newsletter-email">
    <label for="edit-newsletter-email">Email Address</label>
    <input class="form-email form-text" data-drupal-selector="edit-newsletter-email" type="text" id="edit-newsletter-email" name="newsletter_email" value="" size="60" maxlength="128">
    <span class="field-suffix">
      <div class="result_message newsletter_error"></div>
    </span>
  </div>
  <input class="omnitrack button js-form-submit form-submit" data-omnilink="inline-modernhealthcarealert" data-omnilocation="newsletter-component" data-omnievent="event10" data-drupal-selector="edit-newsletter-button" data-disable-refocus="true"
    type="submit" id="edit-newsletter-button" name="op" value="Submit" data-once="drupal-ajax">
  <div data-drupal-selector="edit-captcha" class="captcha"><input data-drupal-selector="edit-captcha-sid" type="hidden" name="captcha_sid" value="72090046">
    <input data-drupal-selector="edit-captcha-token" type="hidden" name="captcha_token" value="RslKveMkXFPnaiRBSz4CXv0VwiIUwzgKrBaJbTusK38">
    <input data-drupal-selector="edit-captcha-response" type="hidden" name="captcha_response" value="Google no captcha">
    <div class="g-recaptcha" data-sitekey="6LddM-oZAAAAAL3-3V972vvwLyB_bHrM-eJrs5w7" data-theme="light" data-type="image">
      <div style="width: 304px; height: 78px;">
        <div><iframe title="reCAPTCHA"
            src="https://www.google.com/recaptcha/api2/anchor?ar=1&amp;k=6LddM-oZAAAAAL3-3V972vvwLyB_bHrM-eJrs5w7&amp;co=aHR0cHM6Ly93d3cubW9kZXJuaGVhbHRoY2FyZS5jb206NDQz&amp;hl=en&amp;type=image&amp;v=QENb_qRrX0-mQMyENQjD6Fuj&amp;theme=light&amp;size=normal&amp;cb=hwkuz3v9ny4c"
            width="304" height="78" role="presentation" name="a-v3amd0gpvp9h" frameborder="0" scrolling="no" sandbox="allow-forms allow-popups allow-same-origin allow-scripts allow-top-navigation allow-modals allow-popups-to-escape-sandbox"></iframe>
        </div><textarea id="g-recaptcha-response" name="g-recaptcha-response" class="g-recaptcha-response"
          style="width: 250px; height: 40px; border: 1px solid rgb(193, 193, 193); margin: 10px 25px; padding: 0px; resize: none; display: none;"></textarea>
      </div><iframe style="display: none;"></iframe>
    </div><input data-drupal-selector="edit-captcha-cacheable" type="hidden" name="captcha_cacheable" value="1">
  </div>
  <input data-drupal-selector="edit-newsletter-parameters" type="hidden" name="newsletter_parameters" value="inline-modernhealthcarealert Submit https://home.modernhealthcare.com/clickshare/extAPI1ChangeServicesAdd.do selection.AlertNewsletter=Y">
  <input autocomplete="off" data-drupal-selector="form-b0ibzhnkj7tt8bl64i4qs4qioqjvhir7sqiptxqj3qe" type="hidden" name="form_build_id" value="form-B0ibzhNkJ7Tt8bl64i4qs4QioQJVHiR7SQIPTxQJ3QE">
  <input data-drupal-selector="edit-newsletter-widget-signup-form-1" type="hidden" name="form_id" value="newsletter_widget_signup_form _1">
  <input data-drupal-selector="edit-field-emphasis-image" type="hidden" name="field_emphasis_image" value="">
</form>

POST /politics-policy/white-house-without-funding-us-will-lose-covid-treatments

<form class="newsletter-signup-form" data-drupal-selector="newsletter-signup-form" action="/politics-policy/white-house-without-funding-us-will-lose-covid-treatments" method="post" id="newsletter-signup-form" accept-charset="UTF-8"
  data-once="form-updated" data-drupal-form-fields="edit-newsletter-email--2,edit-newsletter-button--2">
  <div class="js-form-item form-item js-form-type-textfield form-type-textfield js-form-item-newsletter-email form-item-newsletter-email">
    <label for="edit-newsletter-email--2">Email Address</label>
    <input class="form-email form-text" data-drupal-selector="edit-newsletter-email" type="text" id="edit-newsletter-email--2" name="newsletter_email" value="" size="60" maxlength="128">
  </div>
  <input class="omnitrack button js-form-submit form-submit" data-omnilink="footer" data-omnilocation="newsletter-component" data-omnievent="event10" data-drupal-selector="edit-newsletter-button" type="submit" id="edit-newsletter-button--2" name="op"
    value="Sign Up">
  <input data-drupal-selector="edit-newsletter-parameters" type="hidden" name="newsletter_parameters" value="Sign Up https://home.modernhealthcare.com/clickshare/changeServicesAdd.do CSActivate=true&amp;CSReferrer=web footer">
  <input autocomplete="off" data-drupal-selector="form-eappk5apsk0cbygcnzipivhvxk9ashrhdncywvq25fs" type="hidden" name="form_build_id" value="form-EAPPK5aPsk0CbYgcNZipIVhvxk9aShRhdNCYWvq25fs">
  <input data-drupal-selector="edit-newsletter-signup-form" type="hidden" name="form_id" value="newsletter_signup_form">
  <input data-drupal-selector="edit-field-emphasis-image" type="hidden" name="field_emphasis_image" value="">
</form>

Text Content

Menu
Menu
 * News
 * Digital Health
 * Insights
 * Data/Lists
 * Op-Ed
 * Awards
 * Events
 * Listen
 * Advertise
 * Media Kit
 * Newsletters
 * Jobs
 * People on the Move
 * Reprints & Licensing


News
 * Current News
 * COVID-19
 * Providers
 * Insurance
 * Government
 * Finance
 * Technology
 * Safety & Quality
 * Transformation
   * Patients
   * Operations
   * Care Delivery
   * Payment
 * People
 * Regional News
   * Midwest
   * Northeast
   * South
   * West
 * Digital Edition (Web Version)

Insights
 * ACA 10 Years After
 * Best Practices
 * Special Reports
 * Innovations

Data/Lists
 * Rankings/Lists
 * Interactive Databases
 * Data Points

Op-Ed
 * Bold Moves
 * Breaking Bias
 * Commentaries
 * Letters
 * Vital Signs Blog
 * From the Editor

Awards
 * Nominate/Eligibility
 * 100 Most Influential People
 * 50 Most Influential Clinical Executives
 * Best Places to Work in Healthcare
 * Excellence in Governance
 * Health Care Hall of Fame
 * Healthcare Marketing Impact Awards
 * Top 25 Emerging Leaders
 * Top 25 Innovators
 * Diversity in Healthcare
   * - Luminaries
   * - Top 25 Diversity Leaders
   * - Leaders to Watch
 * Women in Healthcare
   * - Luminaries
   * - Top 25 Women Leaders
   * - Women to Watch

Events
 * Conferences
   * Transformation Summit
   * Women Leaders in Healthcare Conference
   * Social Determinants of Health Symposium
   * Leadership Symposium
 * Galas
   * Health Care Hall of Fame Gala
   * Top 25 Women Leaders Gala
   * Best Places to Work Awards Gala
   * Top 25 Diversity Leaders Gala
 * Virtual Briefings
   * - Hospital of the Future
   * - Value Based Care
   * - Supply Chain Revenue Cycle
   * - Hospital at Home
   * - Workplace of the Future
   * - Strategic Marketing
   * - Virtual Health
 * Webinars

Listen
 * Podcast - Next Up
 * Podcast - Beyond the Byline
 * Sponsored Podcast - Healthcare Insider
 * Video Series - The Check Up
 * Sponsored Video Series - One on One

Skip to main content
Subscribe
 * My Account
 * Login
 * Subscribe

 * News
    * Current News
    * COVID-19
    * Providers
    * Insurance
    * Government
    * Finance
    * Technology
    * Safety & Quality
    * Transformation
    * People
    * Regional News
    * Digital Edition (Web Version)
   
   Patients Operations Care Delivery Payment
   
   Midwest Northeast South West

 * Digital Health
 * Insights
    * ACA 10 Years After
    * Best Practices
    * Special Reports
    * Innovations
   
   
 * Data/Lists
    * Rankings/Lists
    * Interactive Databases
    * Data Points
   
   
 * Op-Ed
    * Bold Moves
    * Breaking Bias
    * Commentaries
    * Letters
    * Vital Signs Blog
    * From the Editor
   
   
 * Awards
    * Nominate/Eligibility
    * 100 Most Influential People
    * 50 Most Influential Clinical Executives
    * Best Places to Work in Healthcare
    * Excellence in Governance
    * Health Care Hall of Fame
    * Healthcare Marketing Impact Awards
    * Top 25 Emerging Leaders
    * Top 25 Innovators
    * Diversity in Healthcare
    * Women in Healthcare
   
   - Luminaries - Top 25 Diversity Leaders - Leaders to Watch
   
   - Luminaries - Top 25 Women Leaders - Women to Watch

 * Events
    * Conferences
    * Galas
    * Virtual Briefings
    * Webinars
   
   Transformation Summit Women Leaders in Healthcare Conference Social
   Determinants of Health Symposium Leadership Symposium
   
   Health Care Hall of Fame Gala Top 25 Women Leaders Gala Best Places to Work
   Awards Gala Top 25 Diversity Leaders Gala
   
   - Hospital of the Future - Value Based Care - Supply Chain Revenue Cycle -
   Hospital at Home - Workplace of the Future - Strategic Marketing - Virtual
   Health

 * Listen
    * Podcast - Next Up
    * Podcast - Beyond the Byline
    * Sponsored Podcast - Healthcare Insider
    * Video Series - The Check Up
    * Sponsored Video Series - One on One
   
   
 * MORE +
    * Advertise
    * Media Kit
    * Newsletters
    * Jobs
    * People on the Move
    * Reprints & Licensing
   
   



MENU
Breadcrumb
 1. Home
 2. Politics & Policy



April 25, 2022 10:03 PM


WHITE HOUSE: WITHOUT FUNDING US WILL LOSE COVID TREATMENTS

Associated Press
 * Tweet
 * Share
 * Share
 * Email
 * 
 * 
 * More
   

Reprints Print
MH Illustration


For much of the past two years, America has been first in line for COVID-19
vaccines and treatments. Now, as drugmakers develop the next generation of
therapies, the White House is warning that if Congress doesn’t act urgently the
U.S. will have to take a number.

Already the congressional stalemate over virus funding has forced the federal
government to curtail free treatment for the uninsured and to ration monoclonal
antibody supplies. And Biden administration officials are expressing increasing
alarm that the U.S. is also losing out on critical opportunities to secure
booster doses and new antiviral pills that could help the country maintain its
reemerging sense of normalcy, even in the face of potential new variants and
case spikes.

Japan, Vietnam, the Philippines, and Hong Kong have all placed orders for
treatments and vaccine doses that the U.S. can't yet commit to, according to the
White House.



Months ago, the White House began warning that the country had spent through the
money in the $1.9 trillion American Rescue Plan that was dedicated directly to
COVID-19 response. It requested an additional $22.5 billion for what it called
“urgent” needs in both the U.S. and abroad.



The Senate last month closed in on smaller $10 billion package focused on
domestic needs. But even that deal fell apart as lawmakers objected to an
announcement from the Centers for Disease Control and Prevention that it would
end Trump-era border restrictions related to the pandemic.

The White House this week is mounting a push for doctors to get less stingy
about prescribing the antiviral pill Paxlovid, which was initially rationed for
those at the highest risk for severe outcomes from COVID-19 but is now more
widely available. A 20 million-dose order placed last year by the government
helped boost manufacturing capacity.

MODERN HEALTHCARE ALERT: SIGN UP FOR THIS BREAKING NEWS EMAIL TO BE KEPT IN THE
LOOP AS URGENT HEALTHCARE BUSINESS NEWS UNFOLDS.

Email Address



Paxlovid, when administered within five days of symptoms appearing, has been
proven to bring about a 90% reduction in hospitalizations and deaths among
patients most likely to get severe disease. Some 314 Americans are now dying
each day from the coronavirus, down from more than 2,600 during the height of
the omicron wave earlier this year.

The U.S. used similar advance-purchase agreements to boost the domestic supply
and manufacture of COVID-19 vaccines, through what was known in the Trump
administration as “Operation Warp Speed.”

Now, with a new generation of treatments on the horizon, the U.S. is falling
behind.

Japan has already placed an initial order for drugmaker Shionogi’s upcoming
COVID-19 antiviral pill, which studies have shown to be at least as effective as
Pfizer’s treatment and has fewer drug-to-drug interactions and is easier to
administer.

Because of the funding delays, officials say, the U.S. has yet to place an
advance order, which would help the company scale manufacturing to widely
produce the pill.

“We know companies are working on additional, promising life-saving treatments
that could protect the American people, and without additional funding from
Congress, we risk losing out on accessing these treatments, as well as tests and
vaccines, while other countries get in front of us in line,” said White House
spokesman Kevin Munoz. “Congress must act urgently upon return from recess to
provide the funding needed to secure new treatments for the American people and
to avoid this dangerous outcome.”

Complicating matters further are the long lead times to manufacture the
antiviral and antibody treatments. Paxlovid takes about six months to produce,
and monoclonal antibody treatments used to treat COVID-19 and prevent serious
disease in the immunocompromised take similarly long, meaning the U.S. is
running out of time to replenish its stockpile before the end of the year.

Last month the White House began cutting back shipments of monoclonal antibody
treatments to states to make supplies last longer.

Administration officials declined to discuss specific treatments they are
stymied from ordering because of contracting requirements.

The funding debate is also holding up U.S. purchases of COVID-19 vaccine booster
doses, including an upcoming new generation of vaccines that may better protect
against the omicron variant.

Moderna and Pfizer both are testing what scientists call “bivalent” shots — a
mix of each company’s original vaccine and an omicron-targeted version — with
Moderna announcing last week it hopes to have its version ready this fall.

The Biden administration has said that while the U.S. has enough vaccine doses
for children under 5, once they are approved by regulators, and for fourth shots
for high-risk people over 50, it doesn’t have the money to order the new
generation of doses.

Earlier this month, former White House COVID-19 coordinator Jeff Zients said
Japan, Vietnam, the Philippines, and Hong Kong had already secured future
booster doses.

Republicans have shown no signs of backing down from their insistence that
before supplying the 10 GOP votes needed for the COVID-19 funding package to
pass the Senate, the chamber must vote on their effort to extend the Trump-era
Title 42 order. That COVID-linked order, which requires authorities to
immediately expel nearly all migrants at the border, is set to be lifted on May
23.

An election-year vote to extend that order would be perilous for Democrats, and
many hope no such vote occurs. Many say privately they hope Biden will keep the
immigration curbs in place or that a court will postpone the rules’ termination,
but Republicans could well force a vote anyway.

“Congress would have to take action in order for the day not to be May 23,”
White House press secretary Jen Psaki said Monday.

Senate Majority Leader Chuck Schumer, D-N.Y., said early this month that he
expected legislation this spring that would wrap together funds for COVID-19 and
Ukraine. Aid for Ukraine has wide bipartisan support and could help propel such
a package through Congress, but Republican opposition has already forced
legislators to strip out pandemic response funding once.

There are at least six Democrats, and potentially 10 or more, who would be
expected to back the Republican amendment to extend the immigration order,
enough to secure its passage.

Such a vote would be dangerous for Democrats from swing districts, who must
appeal to pro-immigration core Democratic voters without alienating moderates
leery of the increase in migrants that lifting the curbs is expected to prompt.

Republicans haven’t said what language they would embrace, but they could turn
to a bipartisan bill by Sens. James Lankford, R-Okla., and Kyrsten Sinema,
D-Ariz.

It would delay any suspension of the immigration limits until at least 60 days
after the U.S. surgeon general declares the pandemic emergency to be over. The
administration would also have to propose a plan for handling the anticipated
increase in migrants crossing the border. Democrats expressing support for
keeping the immigration restrictions in place have cited a lack of planning by
the administration as their chief concern although the Biden administration has
insisted it is preparing for an increase in border crossings.

Letter
to the
Editor

Send us a letter

Have an opinion about this story? Click here to submit a Letter to the Editor,
and we may publish it in print.

Recommended for You
Administration expands availability of COVID antiviral pill
Philadelphia to end mask mandate, days after reinstating it

Sponsored Content


Get Newsletters

Sign up for enewsletters and alerts to receive breaking news and in-depth
coverage of healthcare events and trends, as they happen, right to your inbox.

Email Address
Subscribe Today


MH magazine offers content that sheds light on healthcare leaders’ complex
choices and touch points—from strategy, governance, leadership development and
finance to operations, clinical care, and marketing.

Subscribe
Connect with Us
 * LinkedIn
 * Twitter
 * Facebook
 * RSS
 * Instagram

Our Mission

Modern Healthcare empowers industry leaders to succeed by providing unbiased
reporting of the news, insights, analysis and data.



Contact Us

(877) 812-1581

Email us

 

Resources
 * Contact Us
 * Advertise with Us
 * Ad Choices
 * Sitemap

Editorial Dept
 * Submission Guidelines
 * Code of Ethics
 * Awards
 * About Us

Legal
 * Terms and Conditions
 * Privacy Policy
 * Privacy Request


Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.

Durch die Nutzung der Crain-Website stimmen Sie unserer Verwendung von Cookies
zu.
Ich stimme der Verwendung von Cookies zu Alle Ablehnen Möchten Sie mehr
erfahren? Bitte lesen Sie unsere Cookie-Richtlinie



Close




Modern Healthcare Alerts will keep you in the loop as urgent healthcare business
news unfolds.

Sign Up